Loading…
Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹96,694.50Qualified Make: Bayer
Model: Nubeqa 300mg
Title: TAB DAROLUTAMIDE 300 MG SHOP NO 110A PRESTIGE POINT PREMISES CO OPERATIVE SOCIETY 283 SHUKRAWAR PETH PUNE PUNE MAHARASHTRA 411002 | PUNE | MAHARASHTRA | 411002 | Make: Bayer
Model: Nubeqa 300mg
Title: TAB DAROLUTAMIDE 300 MG | L1 | Qualified MII | |
| 2 | Disqualified Make: NA
Model: TAB DAROLUTAMIDE 300 MG
Title: TAB DAROLUTAMIDE 300 MG | Make: NA
Model: TAB DAROLUTAMIDE 300 MG
Title: TAB DAROLUTAMIDE 300 MG | - | Disqualified MII |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
17 Mar 2026, 3:00 pmClosed
TAB DAROLUTAMIDE 300 MG
8920030
GEM/2026/B/7181074
Two Packet Bid
TAB DAROLUTAMIDE 300 MG
Maharashtra; Pune
Total value wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
1 yrs
₹8 L
₹45 L
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| TAB DAROLUTAMIDE 300 MG | PUNE CITY | 42 | 45 days |
Commandant, Command Hospital Southern Command Pune 411040, Department of Military Affairs, Indian Army, Ministry of, Defence, (Maj Gen Sanil Mohan)
Exempted
Yes
17 Mar 2026
24 Feb 2026
17 Mar 2026
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8920030.pdf
GEM_BID
justification_pac_16_2026-02-02-16-37-50_19bfc7796339917bef78dfcb90986d7d.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
justification_pac_16_2026-02-02-16-37-50_19bfc7796339917bef78dfcb90986d7d.pdf
GEM_SPEC • 0.56 MB
list-of-categories-where-trials-are-allowed_1712126171.pdf
GEM_OTHER • 0.52 MB
gtc.pdf
GEM_OTHER • 0.70 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .